Where does Biontech SE rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biontech SE ranks #5,346 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biontech SE hold?

Biontech SE holds 64 US utility patents granted between 2019 and 2025, spanning 24 technology areas.

What is Biontech SE's Innovation Score?

Biontech SE has an Innovation Score of 64.9 out of 100 (top 1% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Biontech SE focus on?

Biontech SE's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 48 patents, ranking #374 of 6,058 assignees active in that subclass. Grants appear in 24 CPC subclasses total.

Is Biontech SE's patent grant rate increasing or decreasing?

Biontech SE's recent grant velocity is +4500% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Biontech SE's patents?

Biontech SE's patents average 21.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biontech SE patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Biontech SE

USPTO PatentsView assignee record - 64 granted patents across 24 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biontech ranks #5,346 of 49,997 tracked US assignees by granted-patent volume, with 64 patents across 24 technology areas.

#5,346
of 49,997 US assignees by volume: Top 1%
by Innovation Score (64.9/100): 21.9
avg claims per patent: +4500%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5346 · Foreign Corporation #5,346 · 64 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-STRONG · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 64 grants
UPPER-Q #5,346/49,997
PHOTO-FINISH Alma Mater STUDIORUM…
CPC-FOCUS A61P · 24 areas
INNOV-STRONG 64.9/100
CLAIMS-DENSE 21.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +4500% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Alma Mater STUDIORUM—UNIVERSITÀ DI Bologna (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biontech’s 64.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.4 pts (22%) Velocity 20.0 pts (31%) Breadth 17.3 pts (27%) Claim depth 13.2 pts (20%)

Qualcomm Incorporated · highest

85
AAC Microtech… · near

65
Biontech SE · this assignee

65
Mako Surgical · near

65
Regents of the… · near

65
STMicroelectronics… · near

65
3D Lighting… · lowest

7

What this shows Biontech's Innovation Score is 64.9/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biontech?

Each dot is one of Biontech’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biontech’s own 21.9 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biontech vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biontech's grants concentrate

Biontech SE is a focused PatentsView assignee: 24 CPC subclasses with 75% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2024 (16 grants) versus a trough of 1 in 2019. By volume, Biontech sits between iBiquity Digital Corporation and Bradley Company, LLC.

Biontech's three-year grant acceleration

Biontech SE shows 38 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

ibiquity Digital

65
thyssenkrupp Bils…

65
Alma Mater Studio…

64
Beijing Geekplus…

64
BOS & KG

64
Beijing Universit…

64
Beijing Xiaomi Pi…

64
Bradley

64
Biontech SE ◀

64

What this shows Biontech holds 64 patents at rank #5,344, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biontech

By rank, the assignees closest to #5,344 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Biontech's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Biontech, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Biontech ranks #374 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (65 here).

AAC Microtech (Changzhou) Co., Ltd. 65 STMicroelectronics (Research & Development) Limited 65 Mako Surgical Corp. 65 Regents of the University of Minnesota 65

Similar claim depth

Nearest assignees by average claims per patent (21.9 here).

IGT Canada Solutions ULC 21.9 avg Wilson Electronics, LLC 21.9 avg WMS Gaming, Inc. 21.9 avg Senseonics, Incorporated 21.9 avg

Biontech's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

65 Top 1% higher than 99% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Biontech SE patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	1.6%
2020	2	3.1%
2021	6	9.4%
2022	12	18.8%
2023	10	15.6%
2024	16	25.0%
2025partial year	17	26.6%

Which technologies does Biontech SE patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 48

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 48

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 27

C07K - Peptides 24

Y02A - Technologies FOR Adaptation TO Climate Change 13

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 13

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 8

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 7

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

C07D - Heterocyclic Compounds 3

G06T - Image Data Processing OR Generation, IN General 2

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

G06V - Image OR Video Recognition OR Understanding 1

A61B - DIAGNOSIS; SURGERY; Identification 1

G06F - Electric Digital Data Processing 1

Top 15 of 24 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Biontech SE's patent record in context - here's where to go next.

Biontech SE's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 75% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #5,346 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Biontech SE against iBiquity Digital Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 64.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.